Effectiveness of COVID-19 vaccines against SARS-CoV-2 variants of concern: a systematic review and meta-analysis
B Zeng, L Gao, Q Zhou, K Yu, F Sun - BMC medicine, 2022 - Springer
Background It was urgent and necessary to synthesize the evidence for vaccine
effectiveness (VE) against SARS-CoV-2 variants of concern (VOC). We conducted a …
effectiveness (VE) against SARS-CoV-2 variants of concern (VOC). We conducted a …
[HTML][HTML] Covid-19: virology, variants, and vaccines
Abstract As of 25 January 2022, over 349 million individuals have received a confirmed
diagnosis of covid-19, with over 5.59 million confirmed deaths associated with the SARS …
diagnosis of covid-19, with over 5.59 million confirmed deaths associated with the SARS …
[HTML][HTML] Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA vaccination in preventing COVID-19–associated emergency department and urgent care …
NP Klein - MMWR. Morbidity and mortality weekly report, 2022 - cdc.gov
Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing
COVID-19–Associated Emergency Department and Urgent Care Encounters and …
COVID-19–Associated Emergency Department and Urgent Care Encounters and …
[HTML][HTML] Effectiveness of 2-dose BNT162b2 (Pfizer BioNTech) mRNA vaccine in preventing SARS-CoV-2 infection among children aged 5–11 years and adolescents …
AL Fowlkes - MMWR. Morbidity and mortality weekly report, 2022 - cdc.gov
Effectiveness of 2-Dose BNT162b2 (Pfizer BioNTech) mRNA Vaccine in Preventing SARS-CoV-2
Infection Among Children Aged 5–11 Years and Adolescents Aged 12–15 Years — PROTECT …
Infection Among Children Aged 5–11 Years and Adolescents Aged 12–15 Years — PROTECT …
Vaccine effectiveness of two-dose BNT162b2 against symptomatic and severe COVID-19 among adolescents in Brazil and Scotland over time: a test-negative case …
PTV Florentino, T Millington… - The Lancet Infectious …, 2022 - thelancet.com
Background Little is known about vaccine effectiveness over time among adolescents,
especially against the SARS-CoV-2 omicron (B. 1.1. 529) variant. This study assessed the …
especially against the SARS-CoV-2 omicron (B. 1.1. 529) variant. This study assessed the …
Association of COVID-19 vaccination with symptomatic SARS-CoV-2 infection by time since vaccination and Delta variant predominance
A Britton, KE Fleming-Dutra, N Shang, ZR Smith… - Jama, 2022 - jamanetwork.com
Importance Monitoring COVID-19 vaccine performance over time since vaccination and
against emerging variants informs control measures and vaccine policies. Objective To …
against emerging variants informs control measures and vaccine policies. Objective To …
Safety and efficacy of COVID‐19 vaccines in children and adolescents: A systematic review of randomized controlled trials
F Tian, R Yang, Z Chen - Journal of medical virology, 2022 - Wiley Online Library
To systematically review and synthesize the safety and efficacy of coronavirus disease‐2019
(COVID‐19) vaccines in children and adolescents. PubMed, EMBASE, Web of Science …
(COVID‐19) vaccines in children and adolescents. PubMed, EMBASE, Web of Science …
Effectiveness associated with BNT162b2 vaccine against emergency department and urgent care encounters for delta and omicron SARS-CoV-2 infection among …
SY Tartof, TB Frankland, JM Slezak… - JAMA network …, 2022 - jamanetwork.com
Importance Data about the duration of protection of 2 and 3 doses of BNT162b2 in children
and adolescents are needed to help inform recommendations for boosters in this age group …
and adolescents are needed to help inform recommendations for boosters in this age group …
Effectiveness of the BNT162b2 (Pfizer-BioNTech) vaccine in children and adolescents: a systematic review and meta-analysis
JM Sabu, I Zahid, N Jacob, FO Alele, BS Malau-Aduli - Vaccines, 2022 - mdpi.com
Efforts to control the COVID-19 pandemic have expanded to the vaccination of children and
adolescents. This systematic review assesses the utility of the BNT162b2 (Pfizer-BioNTech) …
adolescents. This systematic review assesses the utility of the BNT162b2 (Pfizer-BioNTech) …
Vaccine effectiveness with BNT162b2 (Comirnaty, Pfizer-BioNTech) vaccine against reported SARS-CoV-2 Delta and Omicron infection among adolescents, Norway …
L Veneti, JD Berild, SV Watle, J Starrfelt… - MedRxiv, 2022 - medrxiv.org
Background COVID-19 vaccination was recommended for adolescents in Norway since
August 2021. In this population-based cohort study, we estimated the BNT162b2 vaccine …
August 2021. In this population-based cohort study, we estimated the BNT162b2 vaccine …